Literature DB >> 31775943

The 'Top 10' Challenges for Health Technology Assessment: INAHTA Viewpoint.

Brian O'Rourke1, Sophie Söderholm Werkö2, Tracy Merlin3, Li Ying Huang4, Tara Schuller5.   

Abstract

The International Network of Agencies for Health Technology Assessment (INAHTA) spans the globe as a network of 50 publicly-funded health technology assessment (HTA) agencies supporting health system decision making for 1.4 billion people in thirty countries. Agency members are non-profit HTA organizations that are part of, or directly support, regional or national governments. Recently, INAHTA surveyed its members to gather perspectives from agency leadership on the most important issues in HTA today. This paper describes the top 10 challenges identified by INAHTA members. Addressing these challenges requires a call for action from INAHTA member agencies and the many other actors involved in the HTA ecosystem. In opening this call for action, INAHTA will lead the way; however, a comprehensive undertaking from all players is needed to effectively address these challenges and to continue to evolve HTA in its role as a strong and effective contributor to health systems.

Entities:  

Keywords:  Biomedical; Leadership; Policy; Technology Assessment

Year:  2019        PMID: 31775943     DOI: 10.1017/S0266462319000825

Source DB:  PubMed          Journal:  Int J Technol Assess Health Care        ISSN: 0266-4623            Impact factor:   2.188


  8 in total

1.  A pilot study assessing the similarity between core outcome sets and outcomes included in health technology assessments.

Authors:  Peter Cox; Paula R Williamson; Susanna Dodd
Journal:  F1000Res       Date:  2021-10-25

2.  Patients and public are important stakeholders in health technology assessment but the level of involvement is low - a call to action.

Authors:  Janet L Wale; Samuel Thomas; Dominique Hamerlijnck; Ronald Hollander
Journal:  Res Involv Engagem       Date:  2021-01-05

Review 3.  The Utility of a Rapid Review Evaluation Process to a National HTA Agency.

Authors:  Áine Varley; Lesley Tilson; Emer Fogarty; Laura McCullagh; Michael Barry
Journal:  Pharmacoeconomics       Date:  2021-10-12       Impact factor: 4.981

4.  Can We Afford to Exclude Patients Throughout Health Technology Assessment?

Authors:  Janet L Wale; David Chandler; Deborah Collyar; Dominique Hamerlijnck; Roberto Saldana; Zack Pemberton-Whitely
Journal:  Front Med Technol       Date:  2022-01-25

5.  Solving the Evidence Interpretability Crisis in Health Technology Assessment: A Role for Mechanistic Models?

Authors:  Eulalie Courcelles; Jean-Pierre Boissel; Jacques Massol; Ingrid Klingmann; Riad Kahoul; Marc Hommel; Emmanuel Pham; Alexander Kulesza
Journal:  Front Med Technol       Date:  2022-02-24

6.  Patient Involvement in the Health Technology Assessment Process in Taiwan.

Authors:  Kuei An Chen; Li Ying Huang; Churn Shiouh Gau
Journal:  Front Med Technol       Date:  2022-01-21

7.  Evaluating Public Health Interventions: A Neglected Area in Health Technology Assessment.

Authors:  Jovana Stojanovic; Markus Wübbeler; Sebastian Geis; Eva Reviriego; Iñaki Gutiérrez-Ibarluzea; Irene Lenoir-Wijnkoop
Journal:  Front Public Health       Date:  2020-04-22

8.  The Place and Importance of Patients in Deliberative Processes.

Authors:  Marjo S Cellier
Journal:  Front Med Technol       Date:  2021-11-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.